Evidence map›Paper›PMID 36555856›Full record

ArticleInternational journal of molecular sciences2022

DNA Methylation Alterations in Fractionally Irradiated Rats and Breast Cancer Patients Receiving Radiotherapy.

Magy Sallam, Mohamed Mysara, Mohammed Abderrafi Benotmane, Radia Tamarat, Susana Constantino Rosa Santos, Anne P G Crijns, Daan Spoor, Filip Van Nieuwerburgh, Dieter Deforce, Sarah Baatout and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Magy SallamRadiobiology Unit, Interdisciplinary Biosciences, Belgian Nuclear Research Centre, SCK CEN, 2400 Mol, Belgium.ORCID 0000-0002-3040-8993
Mohamed MysaraRadiobiology Unit, Interdisciplinary Biosciences, Belgian Nuclear Research Centre, SCK CEN, 2400 Mol, Belgium.
Mohammed Abderrafi BenotmaneRadiobiology Unit, Interdisciplinary Biosciences, Belgian Nuclear Research Centre, SCK CEN, 2400 Mol, Belgium.
Radia TamaratInstitut de Radioprotection et de Sureté Nucléaire (IRSN), PRP-HOM, SRBE, LR2I, 92260 Fontenay-aux-Roses, France
Susana Constantino Rosa SantosCentro Cardiovascular da Universidade de Lisboa (CCUL@RISE), Lisbon School of Medicine of the Universidade de Lisboa, 1649-028 Lisbon, Portugal
Anne P G CrijnsDepartment of Radiation Oncology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.
Daan SpoorDepartment of Radiation Oncology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.
Filip Van NieuwerburghLaboratory of Pharmaceutical Biotechnology, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0001-8815-5485
Dieter DeforceLaboratory of Pharmaceutical Biotechnology, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0002-0635-661X
Sarah BaatoutRadiobiology Unit, Interdisciplinary Biosciences, Belgian Nuclear Research Centre, SCK CEN, 2400 Mol, Belgium.ORCID 0000-0001-8110-751X
Pieter-Jan GunsLaboratory of Physiopharmacology, University of Antwerp, 2610 Wilrijk, Belgium.ORCID 0000-0002-8640-6620
An AertsRadiobiology Unit, Interdisciplinary Biosciences, Belgian Nuclear Research Centre, SCK CEN, 2400 Mol, Belgium.
Raghda RamadanRadiobiology Unit, Interdisciplinary Biosciences, Belgian Nuclear Research Centre, SCK CEN, 2400 Mol, Belgium.ORCID 0000-0002-6826-7858
Belgian Nuclear Research Centre · BEGhent University · BEUniversity Medical Center Groningen · NLUniversity of Antwerp · BEInstitut de Radioprotection et de Sûreté Nucléaire · FRUniversity of Lisbon · PT

Funding

Euratom research and training Horizon 2020 2014-2018 programme 755523
6 · The paper itself

Abstract

Radiation-Induced CardioVascular Disease (RICVD) is an important concern in thoracic radiotherapy with complex underlying pathophysiology. Recently, we proposed DNA methylation as a possible mechanism contributing to RICVD. The current study investigates DNA methylation in heart-irradiated rats and radiotherapy-treated breast cancer (BC) patients. Rats received fractionated whole heart X-irradiation (0, 0.92, 6.9 and 27.6 Gy total doses) and blood was collected after 1.5, 3, 7 and 12 months. Global and gene-specific methylation of the samples were evaluated; and gene expression of selected differentially methylated regions (DMRs) was validated in rat and BC patient blood. In rats receiving an absorbed dose of 27.6 Gy, DNA methylation alterations were detected up to 7 months with differential expression of cardiac-relevant DMRs. Of those,

Indexed as

DNA MethylationHeartAnimalsBreast NeoplasmsE2F6 Transcription FactorFemaleHumansLungMembrane ProteinsMutationProtein Processing, Post-TranslationalRatsE2F6 protein, humanE2F6 Transcription FactorMembrane ProteinsSLMAP protein, humanSLMAP protein, ratbreast cancer patientcardiovascular diseaseDNA methylationgene expressionionizing radiation

Identifiers

PMID36555856
PMCPMC9783664
OpenAlexW4311886195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.